Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia (Q69375723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

S H Ralston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

S J Gallacher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

U Patel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

F J Dryburgh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

W D Fraser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

R A Cowan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

I T Boyle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

language of work or name

English

0 references

publication date

1 November 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

8673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

1180-1182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Predictive value of derived calcium figures based on the measurement of ionised calcium.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Nomogram for derivation of renal threshold phosphate concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

The pathogenesis of humoral hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Parathyroid hormone-related protein of malignancy: active synthetic fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Effects of intravenous etidronate disodium on skeletal and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Etidronate disodium in the management of malignancy-related hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

Renal failure associated with intravenous diphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991791-1

7 January 2021

10.1016/S0140-6736(89)91791-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2572902%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference